STRS Ohio’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

STRS Ohio’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-41,300	Closed	-$879K	–	2221
2018 Q2	$1.05M	Buy	41,300 +1,400	+4%	+$32.6K	﹤0.01%	869
2018 Q1	$803K	Hold	39,900	–	–	﹤0.01%	1006
2017 Q4	$800K	Buy	+39,900	New	+$785K	﹤0.01%	999
2015 Q1	–	Sell	-5,300	Closed	-$144K	–	1900
2014 Q4	$145K	Buy	+5,300	New	+$129K	﹤0.01%	1498

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

STRS Ohio's DPLO Position: Q3 2018 in Review

STRS Ohio sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 41,300 shares — an estimated $879K sold.

STRS Ohio first reported a position in DPLO in Q4 2014 and held it in 4 quarters. The position peaked at $1.05M in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

STRS Ohio reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
STRS Ohio sold 41,300 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $879K.
STRS Ohio first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 4 quarters.
STRS Ohio's DIPLOMAT PHARMACY, INC. position peaked at $1.05M in Q2 2018.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on STRS Ohio's 13F filing for Q3 2018, filed 19 Oct 2018.